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Abstract
Background: Constitutional translocations between sex chromosomes are rather rare in humans with breakpoints
at Xp11 and Yq11 as the most frequent. Breakpoints on the short arm of the Y chromosome form one subgroup of
t(X;Y), giving rise to a derived chromosome with the centromeres of both the X and Y chromosomes, dic(X;Y). Here,
we report a rare congenital chromosomal aberration, 46,X,dic(X;Y)(p22.33;p11.32)[20]/45,X[10], in an adult male.
Case presentation: Primary myelofibrosis, a malignant haematological disease, was diagnosed in a 63-year-old
man following liver transplantation after hepatocellular carcinoma. By the analysis of the bone marrow sample, the
karyotype 46,X,dic(X;Y)(p22.33;p11.32) was detected in all the mitoses analysed and verified with multicolour
fluorescence in situ hybridization (mFISH). A cytogenetic examination of stimulated peripheral blood cells revealed
the constitutional karyotype 46,X,dic(X;Y)(p22.33;p11.32)[20]/45,X[10]. The cell line 45,X was confirmed with FISH in
35 % of interphase nuclei. The SRY locus was present on the dicentric chromosome. A CGH/SNP array (Illumina)
revealed a gain of 153,7 Mbp of the X chromosome and a 803-kbp microdeletion (including the SHOX gene), which
were also confirmed with FISH. SHOX encodes a transcriptional factor that regulates the growth of the long bones.
The deletion of the SHOX gene together with the Madelung deformity of the forearm and the short stature of the
proband led to a diagnosis of Léri-Weill dyschondrosteosis (LWD). The gain of almost the whole X chromosome
(153,7 Mbp) was considered a variant of Klinefelter syndrome (KS). The levels of gonadotropins and testosterone
were consistent with gonadal dysfunction. A malformation of the right external ear was detected.
Conclusions: We have reported a structural aberration of the sex chromosomes, dic(X;Y)(p22.33;p11.32). The related
genomic imbalance is associated with two known hereditary syndromes, LWD and a KS variant, identified in our proband
at an advanced age. Because the breakpoints did not involve cancer genes, we inferred that the two malignancies in the
proband were not caused by this abnormality. The possible influence of SHOX haploinsufficiency on the growth
regulation of auricular chondrocytes is discussed.
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Background
Constitutional translocations between the sex chromo-
somes are quite rare in humans and are associated with
abnormal gonadal development. The ultimate phenotype
varies because several other factors are involved: the lo-
cations of the breakpoints on the X and Y chromosomes
and the corresponding genomic imbalances, the pres-
ence/loss of the SRY gene locus, tissue mosaicism and an
irregular X-inactivation pattern. Breakpoints at Xp11
and of the long arm of the Y chromosome (Yq11), with
the loss of the centromere and the SRY gene, are the
most frequently detected changes. Breakpoints on the
short arm of the X and Y chromosomes constitute a rare
subgroup of t(X;Y), giving rise to a derived chromosome
containing the centromeres of both the X and Y chro-
mosomes, dic(X;Y).
The degree of impairment in the carrier depends on
the sex of the individuals and on their sex chromosomes
and on the extent of deleted regions on Xp/Yp, which
can include genes with variable clinical impacts: ichthy-
osis (XLI), chondrodysplasia punctata (STS), ocular al-
binism (ARSE), short stature (SHOX), mental retardation
(MRX49) and Kallman syndrome (GPR143). Large dele-
tions of Xp that include many genes and syndromes in-
volving contiguosly deleted genes have been described in
males [1, 2]. The SHOX gene is localized in pseudoauto-
somal region 1 (PAR1), which is homologous sequence
of nucleotides on both sex chromosomes and comprises
2,6 Mbp at Xp22.33 and Yp11.32. As far as we know, de-
letions of SHOX caused by the formation of dic(X;Y)
have been infrequently cited in the literature, with
male carriers reported by Wei et al. [3], Mutesa et al.
[1], and Mazen et al. [4], and a female carrier of
dic(X;Y) with a more proximal breakpoint at Yp11.2
and the loss of the SRY gene (determining the male
sex) reported by Baralle et al. [5].
Until now, only a few cases of constitutional dic(X;Y),
with identical breakpoints at Xp22.33 and Yp11.32, have
been described. Familial inheritance is uncommon.
McKinley Gardner and Sutherland [6] claimed that this
aberration is always sporadic and arises during abnormal
X–Y recombination within paternal meiosis. However,
the maternal transmission of dic(X;Y)(p22.3;p11.3) was
documented in a study by Wei et al. [3]. A woman with
the karyotype 45,X/46,X,dic(X;Y)(p22.3;p11.3) gave birth
to two children, despite the 80 % 45,X cell line. The con-
tribution of the major 45,X cell line to the female sex is
obvious and her fertility was abnormal (she experienced
premature ovarian failure at an age of < 30 years). Her
son (29 years old at the time of publication) had the
karyotype 46,X,dic(X;Y)(p22.3;p11.3)[20]mat, and Léri-
Weill dyschondrosteosis (LWD) was diagnosed in both
mother and son. The son refused a detailed andrological
examination, but his hormonal profile, which included
increased levels of luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) and reduced testosterone, was
consistent with Klinefelter syndrome (KS).
Mazen et al. [4] described de novo dic(X;Y)(p22.3;p11.3)
in a 14-year old boy with the karyotype 46,X,dic(X;Y)
(p22.3;p11.3)[65]/45,X[23]/45,dic(X;Y)(p22.3;p11.3)[12].
The boy had been observed from birth because he
was born with ambiguous genitalia, he displayed hypospa-
dias and both testicular and ovarian tissues were detected
in his gonads with biopsy. The final diagnosis was ovotes-
ticular disorder of sexual development. DNA sequencing
detected a partial deletion of the 5′ region of the homeo-
box (HMG box) domain of the SRY gene. This deletion
can reduce the expression of SRY and influence its timing
and tissue specificity, and therefore testicular development
[7]. The consequences of SHOX haploinsufficiency and
LWD were not discussed in that report. The boy’s growth
was not yet complete, but its retardation was already ap-
parent (−2SD), and forearm deformity and wrist pain usu-
ally manifest at a later age [8].
SHOX is a regulatory gene encoding a transcription
factor that plays a key role in bone formation and linear
growth, affecting skeletal development and the first and
second pharyngeal arches during embryonal develop-
ment. Its expression pattern parallels the locations of the
anatomic structures that are affected when SHOX is de-
ficient: limbs, maxilla, mandible and external ear tract
[9]. The heterozygous deletion/mutation of SHOX simul-
taneously with the Madelung deformity of the forearm
and a short stature are the main features of LWD. The
phenotype is more distinctive in females because oestro-
gens play a regulatory role in the growth and differenti-
ation of the long bones [8].
Case presentation
A male patient (born in 1953) suffering hepatocellular car-
cinoma (HCC), with a significant ethylic aetiology, under-
went liver transplantation in October 2014. Six cancer
lesions were confirmed in the explant. Because trilinear
extra-medullary haematopoiesis was present, he was exam-
ined by a haematologist, who diagnosed a myeloprolifera-
tive disorder (primary myelofibrosis, PMF). Advanced
disease was identified based on the patient’s histology,
thrombocytosis of 600–700 × 109/l, and normochronic nor-
mocytic anaemia (haemoglobin, 95–110 g/l). Cytoreductive
therapy to reduce the number of platelets was indicated
and successfully administered up to November 2015. Be-
cause the patient’s condition worsened, bone-marrow trans-
plantation was considered, but was postponed because of
comorbidity (health status after liver transplantation). A
homozygous genomic V617F mutation of JAK2 (a diagnos-
tic molecular marker with a negative prognostic impact that
occurs in up to 60 % of PMF) [10] was detected. A cytogen-
etic analysis of a bone-marrow aspirate was performed.
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The bone-marrow cells (collected in November 2014)
were cultured for 24 h without mitogen stimulation, and
chromosomal preparations were made with standard
techniques. At least 20 metaphases were analysed and
the karyotype was described according to the Inter-
national System for Human Cytogenetic Nomenclature
(ISCN 2016) [11]. No chromosomal aberrations related
to the haematological malignancy were found. (Among
the patients with myeloproliferative disorders, the most
common chromosomal abnormalities were 20q–, 13q–,
+8, +9, 1q+, −7/7q– [12]).
The karyotype 46,X,dic(X;Y)(p22.3;p11.3)[22] was de-
tected in all of the mitoses analysed. This finding was con-
firmed with multicolour fluorescence in situ hybridization
(mFISH) using the 24XCyte mFISH kit (MetaSystems,
Altlussheim, Germany) (Fig. 1a and b). FISH performed
with commercially available locus-specific probes (Vysis
LSI SRY, Vysis TelVysion Xp/Yp) confirmed the deletion
of both the subtelomeric regions of Xp/Yp and the present
SRY gene locus (Fig. 1c).
The dicentric chromosome was identified with FISH
and the centromeric probe CEPX (DXZ1)/CEPY (DYZ3)
(Fig. 1d). All probes were from Abbott Molecular (Des
Plaines, IL, USA).
The constitutional karyotype (from peripheral blood
cultured for 72 h with phytohaemagglutinin stimula-
tion) was examined in January 2015. In addition to the
46,X,dic(X;Y)(p22.3;p11.3)[20] translocation, a 45,X[10]
cell line was found. Interphase FISH confirmed the
45,X (monosomy X/loss of SRY gene) cellular clone in
35 % of nuclei.
Comparative genomic hybridization (CGH) and a
single-nucleotide polymorphism (SNP) array (Cytochip
Cancer SNP 4 × 180 K; BlueGnome, Illumina, Cambridge,
UK) discovered the loss of 803,5 kbp at chromosomal
band Xp22.33 (bp 60,726 to 864,243) [the part of pseu-
doautosomal region 1 (PAR1) including the SHOX gene]
and a gain of 153,7 Mbp, extending from Xp22.33 to
Xq28 (bp 1,518,233 to 155,232,885) (Fig. 1g, h and k).
Result of CGH/SNP array analysis is: 46,X,dic(-
X;Y)(p22.33;p11.32).arr[GRCh37]Xp22.33(60726_864243)x
1,Xp22.33q28(1518233_155232885)x2. PAR1 is graphically
displayed only on the X chromosome. Between abnormal
regions, still in PAR1, the region of the size 598,8 kbp was
evaluated as normal (present in two copies). We assume,
that this region is preserved on the Y chromosome and nor-
mal X chromosome (deleted on derived X chromosome).
The Y chromosome was evaluated as normal. Deletion of
the subtelomeric region Yp and the heterozygous deletion
of the SHOX gene were verified with FISH and Aquarius®
Microdeletion Syndrome Probe SHOX (Cytocell) (Fig. 1e).
The patient was examined by a clinical geneticist. An
examination of his parents is not possible anymore and
the available data for other living family members are
very limited. The proband’s mother had a short stature
and the proband was the smallest of six siblings (Fig. 1f ).
No intellectual disability was demonstrated. He is stocky
(height 152 cm, weight 75 kg) with a massive chest, gynae-
comastia, kyphoscoliosis and short limbs (with severely
bowed legs). An uncommon auricular malformation was
visible on the right ear (Fig. 1j).
The features of the forearms, originating from the
bowing radius and the dorsal subluxation of the ulna
(Madelung deformity), were obvious (Fig. 1i). LWD was
diagnosed based on this feature, the patient’s short stat-
ure and the heterozygous deletion of the SHOX gene.
The large gain of 153,7 Mbp of DNA, extending from
Xp22.33 to Xqter, was shown to involve the gain of al-
most the whole X chromosome. The presence of an
additional derived X chromosome can be considered a
Klinefelter syndrome (KS) variant [13]. Despite the
microdeletion, the SRY gene locus at Yp11.3, which is re-
sponsible for male sex determination, was present on
dic(X;Y). The tall stature and narrow shoulders that are
usually associated with KS are masked by the manifesta-
tions of the growth retardation syndrome (LWD). The
proband had a short stature and was stubby. Neither
syndrome was accompanied by the marked malforma-
tions, which typically manifest from birth and/or early
childhood. Only his gynaecomastia has been remarkable
from puberty. The external genitalia can range from am-
biguous to normal male in individuals with KS variant
karyotypes. The patient’s external genitalia were not mal-
formed and normal sexual interaction was presumed, as
has been reported for other individuals with KS [14].
We assume that the partial deletion of the 5′ region of
the HMG box domain of the SRY gene was responsible
for the severe gonadal malformation in the case de-
scribed by Mazen et al. [4]. Our patient’s LH, FSH and
testosterone levels were determined from a blood sam-
ple. Elevated levels of the gonadotropins LH (20.5 U/l;
normal range 1.2–8.6 U/l) and FSH (33 U/l; normal
range 1.3–19.3 U/l) and reduced levels of testosterone
(5.53 nmol/l; normal range 6.10–27.10 nmol/l) are con-
sistent with gonadal dysfunction, and were also detected
in the man reported by Wei et al. [3]. Infertility was ex-
pected. Currently, cytogenetic analysis is an integral part
of the diagnosis in couples with reproductive failure.
Our proband had limited relations with women in the
past, and had made no effort to have children. McKinley
Gardner and Sutherland [6] stated that male carriers of
this translocation are always infertile.
The extent of phenotypic manifestations also depends
on cell mosaicism, the proportion of 46,X,dic(X;Y)/45,X
cells, and their tissue distributions. The significant clin-
ical impact of the 45,X cell line on the development of
different organs has been reported. For example,
Kaprova-Pleskacova et al. [15] reported 46,X,psu dic(Y)
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Fig. 1 Results of conventional and molecular cytogenetic analyses, clinical genetic examination and documentation of the phenotype. G-banded
(a) and multicolour FISH karyotypes (b) showing dic(X;Y)(p22.33;p13.1). FISH with TelVysion probes Xp/Yp (green signal) and LSI SRY (orange signal)
demonstrating the loss of Xp/Yp subtelomeres on the dicentric chromosome and the present SRY gene locus (c). FISH with DXZ1 (green signal)/
DYZ3 (orange signal) (d) and deletion of the SHOX gene on dic(X;Y) confirmed by FISH with the probe containing the probes for the SHOX gene
(orange signal), DXZ1 (blue signal) and DYZ1 (green signal) (e). Result of CGH/SNP array analysis (k). Diagram of the X chromosome (g). Chromosomal
band Xp22.33 in detail (h). Pedigree of the family (f). Arrow indicates the affected proband, question mark indicates the unavailable data about the
offsprings. Photographs of partial phenotype (i, j) revealing forearm deformities and auricular hyperplasia
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in a girl with another cell line 45,X and Portnoï et al.
[16] described a patient with the mosaic karyotype 45,X/
46,X,der(X)t(X;Y)(p11.4;p11.2). In our patient, the SRY
gene was only present in the dic(X;Y) cells, which con-
stituted 65 % of the cells in the peripheral blood. We
infer that SRY-positive cells were predominant in the go-
nadal tissue. The 45,X cell line was not identified by
FISH in the bone-marrow cells of our patient. We as-
sume it had a later postzygotic origin in the peripheral
blood cells, and did not influence the development of
the gonads or other organs.
The malformation of the right external ear after a
scissors-inflicted injury during a haircut is very uncom-
mon. However, ear deformities or hearing failure have
been reported as the consequences of SHOX deletions in
women with Turner’s syndrome, although rarely in co-
horts of LWD patients [17]. However, to our knowledge,
cell dysplasia induced by the healing process of a cut
wound has not been reported. The influence of SHOX ex-
pression on cell proliferation and viability was demon-
strated by Marchini et al. [18]. Generally, wild-type SHOX
induces cell-cycle arrest and apoptosis by altering the ex-
pression of other cell-cycle-regulating proteins in humans
(RUNX2, SOX2) [18]. In the growth plate, hypertrophic
chondrocytes express SHOX, which exerts a potent anti-
proliferative effect. A study of in vitro-cultured human
auricular chondrocytes confirmed the overexpression of
the RUNX2 gene, which implies hypertrophy [19].
SHOX-mediated cell-cycle arrest is altered when SHOX
expression is reduced [20], and we hypothesize that the
hyperplasia of the auricular cartilage could have been
caused in vivo by abnormal levels of cell growth inhibi-
tors, mediated by SHOX haploinsufficiency.
The proband suffered two malignant diseases during his
life: hepatocellular carcinoma and primary myelofibrosis.
The incidence of cancer in carriers of congenital chromo-
somal aberrations has been extensively studied [21]. De
novo germ-line genomic changes can target genes that are
rearranged in cancer, and the breakpoints of germ-line re-
arrangements and somatic rearrangements can overlap.
The molecular basis and genomic context of sporadic de
novo rearrangements are not fully understood. The pheno-
typic outcome may be determined by the timing and con-
text of the rearrangement (involving additional mutations)
[22]. The breakpoints in our patient did not affect any
cancer genes. The cancer risk of KS cohorts is similar
to the general population. Generally, men with KS have an
increased risk of specific malignancies: extragonadal germ-
cell tumours, non-Hodgkin’s lymphoma and breast cancer
[23]. However, the occurrence of multiple cancers has not
been equivocally established in individuals with KS. As
well as hormonal and genetic factors, factors such as obes-
ity and alcohol abuse also played roles in the development
of cancer in our proband.
Conclusion
The unique case of a very rare congenital translocation
between chromosomes X and Y, forming a dicentric
chromosome dic(X;Y)(p22.33;p11.32), was detected when
the proband was at an advanced age. An analysis of the
karyotype in bone-marrow cells, performed to investigate
the patient’s haematological malignancy, first detected the
two associated syndromes in the proband- LWD and
variant KS. Based on data in the literature and the break-
points involved, the two malignant diseases suffered by
the proband are presumed to be unrelated to this inborn
chromosomal aberration.
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